Entero Therapeutics Total Current Liabilities

As of the most recent data (March 2026), ENTO shows a total current liabilities of $16M. That compares with $29M in the prior-year period — down 43.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTO's total current liabilities is now $16M (was $29M) — a 43.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Entero Therapeutics is outperforming or lagging.

Tracking ENTO's total current liabilities over time shows whether Entero Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $29M in the prior-year period — down 43.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Entero Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $16M) with ownership activity and broader fundamentals.